Grifols (GIKLY) Stock Price, News & Analysis
Company Description
Grifols (OTC Link: GIKLY) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $8.7B.
GIKLY has declined 17.0% over the past year. Shares last traded at $5.09.
This page collects what Stock Titan holds for GIKLY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Grifols (GIKLY) stock last closed at $5.09. Over the past 12 months, the stock has lost 17.0%. At a market capitalization of $8.7B, GIKLY is classified as a mid-cap stock with approximately 1.1B shares outstanding.
Latest News
Grifols has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include management, partnership, acquisition. View all GIKLY news →
SEC Filings
Grifols has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on June 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GIKLY SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Grifols (GIKLY) currently stands at 69 shares. Since July 2025, short interest has decreased by 38.9%.
Days to Cover History
Days to cover for Grifols (GIKLY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 53.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
GIKLY Company Profile & Sector Positioning
Grifols (GIKLY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GIKLY often look at related companies in the same sector, including Kyowa Hakko (KYKOY), Ono Pharmace Drc (OPHLY), Pt Kalbe Farma Tbk (PTKFY), Cspc Pharmaceuti (CSPCY), and Astellas Pharma (ALPMY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GIKLY's relative position within its industry.